11.02.22 -- Accelerating Clinical Development For U.S. Biotechs In The Asia Pacific

Delve into how China is now more aligned with international standards, enabling biotech firms to streamline processes and timelines, which has significantly recharged biotech innovation.

During the analysis period between 2017-2021, over 70,000 new clinical trials were registered in the APAC region, the U.S., and the EU. With this changing landscape, explore how APAC is emerging as the new hot spot for conducting clinical trials, especially in China.

The webinar features regulatory affairs and investment leaders from North America and Asia Pacific who will discuss why biotech companies are increasingly exploring clinical opportunities in Asia Pacific to generate diverse, globally accepted clinical trial data, and much more.

Learn how the Asia Pacific has shown significant increase in Immuno-oncology (IO) trials between 2017 and 2021 and contributes to about 35% of clinical development in IO globally.